The Rezon Bio Story: Interview with Dr. Adriana Kiedzierska-Mencfeld
At CDMO Live Europe 2026, Dr. Adriana Kiedzierska-Mencfeld, Chief Executive Officer of Rezon Bio, drew on 11 years of leading operations at Polpharma Biologics to explain why biosimilar developers must address cost strategy in process development, long before any product reaches market.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from PharmaSource Podcast
How To Deliver a High-Concentration Bispecific Antibody Tox Batch in 4 Months
Novartis’ Win-Win Approach to Greener Drug Development
Network Resilience: Why Dual Sourcing Alone Won’t Save You
Building a CMC Strategy That Satisfies Regulators and Attracts Investors
Get summaries like this every morning.
Free AI-powered recaps of PharmaSource Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.